Bioengineering MSCs for untapped therapeutic potential.
作者信息
Sirpilla Olivia, Kenderian Saad S
机构信息
T Cell Engineering, Mayo Clinic, Rochester, MN 55905, USA.
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
出版信息
Immunotherapy. 2024;16(14-15):907-911. doi: 10.1080/1750743X.2024.2390819. Epub 2024 Sep 13.
Abstract
摘要
相似文献
1
Bioengineering MSCs for untapped therapeutic potential.生物工程改造间充质干细胞以挖掘未开发的治疗潜力。
Immunotherapy. 2024;16(14-15):907-911. doi: 10.1080/1750743X.2024.2390819. Epub 2024 Sep 13.
2
Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives.基于间充质干细胞的 COVID-19 治疗：生物工程视角。
Cells. 2022 Jan 29;11(3):465. doi: 10.3390/cells11030465.
3
Functional Biomolecule Delivery Systems and Bioengineering in Cartilage Regeneration.软骨再生中的功能性生物分子递送系统与生物工程
Curr Pharm Biotechnol. 2019;20(1):32-46. doi: 10.2174/1389201020666190206202048.
4
Decellularization with triton X-100 provides a suitable model for human kidney bioengineering using human mesenchymal stem cells.使用 Triton X-100 进行脱细胞处理为人肾生物工程用人间质干细胞提供了一个合适的模型。
Life Sci. 2022 Apr 15;295:120167. doi: 10.1016/j.lfs.2021.120167. Epub 2021 Nov 22.
5
Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering.利用膝关节驻留间充质干细胞进行软骨组织工程。
Acta Biomater. 2023 Sep 15;168:372-387. doi: 10.1016/j.actbio.2023.07.024. Epub 2023 Jul 21.
6
A Systemic Review of Adult Mesenchymal Stem Cell Sources and their Multilineage Differentiation Potential Relevant to Musculoskeletal Tissue Repair and Regeneration.成人间充质干细胞来源及其与肌肉骨骼组织修复和再生相关的多向分化潜能的系统评价。
Curr Stem Cell Res Ther. 2017;12(8):601-610. doi: 10.2174/1574888X12666170608124303.
7
Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.用于骨修复的间充质干细胞：临床前研究及潜在的骨科应用
Foot Ankle Clin. 2005 Dec;10(4):651-65, viii. doi: 10.1016/j.fcl.2005.06.004.
8
Mesenchymal stem cells for tissue engineering and regenerative medicine.用于组织工程和再生医学的间充质干细胞。
Biomed Mater. 2006 Jun;1(2):63-71. doi: 10.1088/1748-6041/1/2/003. Epub 2006 Apr 26.
9
Mesenchymal stem cell 3D encapsulation technologies for biomimetic microenvironment in tissue regeneration.用于组织再生仿生微环境的间充质干细胞 3D 包封技术。
Stem Cell Res Ther. 2019 Feb 7;10(1):51. doi: 10.1186/s13287-018-1130-8.
10
Role of Human Mesenchymal Stem Cells in Regenerative Therapy.人骨髓间充质干细胞在再生治疗中的作用。
Cells. 2020 Dec 31;10(1):54. doi: 10.3390/cells10010054.
引用本文的文献
1
Therapeutic Potential of Chimeric Antigen Receptor-Expressing Mesenchymal Stem Cells in the Treatment of Inflammatory and Autoimmune Diseases.表达嵌合抗原受体的间充质干细胞在炎症性和自身免疫性疾病治疗中的治疗潜力。
Int J Mol Sci. 2025 Aug 12;26(16):7795. doi: 10.3390/ijms26167795.
2
Mesenchymal stromal cell therapy: Progress to date and future outlook.间充质基质细胞疗法：迄今进展与未来展望。
Mol Ther. 2025 Jun 4;33(6):2679-2688. doi: 10.1016/j.ymthe.2025.02.003. Epub 2025 Feb 6.
本文引用的文献
1
Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression.嵌合抗原受体修饰的间充质基质细胞增强免疫抑制作用。
Nat Biomed Eng. 2024 Apr;8(4):443-460. doi: 10.1038/s41551-024-01195-6. Epub 2024 Apr 1.
2
PD-L1 and AKT Overexpressing Adipose-Derived Mesenchymal Stem Cells Enhance Myocardial Protection by Upregulating CD25 T Cells in Acute Myocardial Infarction Rat Model.PD-L1 和 AKT 过表达脂肪间充质干细胞通过上调急性心肌梗死大鼠模型中的 CD25 T 细胞增强心肌保护作用。
Int J Mol Sci. 2023 Dec 21;25(1):134. doi: 10.3390/ijms25010134.
3
New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons.间充质干细胞疗法在肿瘤微环境中的应用新见解：利弊
Front Cell Dev Biol. 2023 Oct 2;11:1255697. doi: 10.3389/fcell.2023.1255697. eCollection 2023.
4
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee.商业批准的间充质基质细胞疗法未能推出：未来之路何在？2023年5月在巴黎会议宫举行的国际细胞与基因治疗协会（ISCT）年会圆桌会议记录，由ISCT间充质干细胞科学委员会组织。
Cytotherapy. 2024 May;26(5):413-417. doi: 10.1016/j.jcyt.2023.09.001. Epub 2023 Oct 7.
5
Three-Dimensional Spheroid Culture of Human Mesenchymal Stem Cells: Offering Therapeutic Advantages and In Vitro Glimpses of the In Vivo State.人骨髓间充质干细胞的三维球体培养：提供治疗优势和对体内状态的体外观察。
Stem Cells Transl Med. 2023 May 15;12(5):235-244. doi: 10.1093/stcltm/szad011.
6
Improved efficacy of mesenchymal stromal cells stably expressing CXCR4 and IL-10 in a xenogeneic graft versus host disease mouse model.稳定表达 CXCR4 和 IL-10 的间充质基质细胞在异种移植物抗宿主病小鼠模型中的疗效改善。
Front Immunol. 2023 Feb 1;14:1062086. doi: 10.3389/fimmu.2023.1062086. eCollection 2023.
7
Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy.间质基质细胞：潜在的微环境调节剂成为细胞治疗。
Cell Stem Cell. 2021 Oct 7;28(10):1708-1725. doi: 10.1016/j.stem.2021.09.006.
8
Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies.嵌合抗原受体 T 细胞疗法的耐药性：从血液系统恶性肿瘤治疗中获得的经验教训。
Leuk Lymphoma. 2021 Sep;62(9):2052-2063. doi: 10.1080/10428194.2021.1894648. Epub 2021 Mar 8.
9
Challenges and advances in clinical applications of mesenchymal stromal cells.间充质基质细胞临床应用的挑战与进展。
J Hematol Oncol. 2021 Feb 12;14(1):24. doi: 10.1186/s13045-021-01037-x.
10
Shattering barriers toward clinically meaningful MSC therapies.打破临床意义上 MSC 疗法的障碍。
Sci Adv. 2020 Jul 22;6(30):eaba6884. doi: 10.1126/sciadv.aba6884. eCollection 2020 Jul.
Zotero 插件